Cited by 168Hormonal and reproductive studiesAdrenal Hormones and DisordersMenopause: Health Impacts and Treatments

Testosterone replacement therapy improves metabolic parameters in hypogonadal men with type 2 diabetes but not in men with coexisting depression: the BLAST study

Hackett, Geoffrey, Cole, Nigel, Bhartia, Mithun, Kennedy, David, Raju, Jessie, Wilkinson, Peter, the BLAST Study Group·2014·The Journal of Sexual Medicine

Abstract

INTRODUCTION: The association between testosterone deficiency and insulin resistance in men with type 2 diabetes is well established and current endocrine society guidelines recommend the measurement of testosterone levels in all men with type 2 diabetes or erectile dysfunction. AIM: We report the first double-blind, placebo-controlled study conducted exclusively in a male type 2 diabetes population to assess metabolic changes with long-acting testosterone undecanoate (TU). METHODS: The type 2 diabetes registers of seven general practices identified 211 patients for a 30-week double-blind, placebo-controlled study of long-acting TU 1,000 mg followed by 52 weeks of open-label use. Because of the established impact of age, obesity, and depression on sexual function, these variables were also assessed for influence on metabolic parameters. MAIN OUTCOME MEASURE: Changes in glycated hemoglobin (HbA1c) and the level of testosterone at which response are achieved. RESULTS: Treatment with TU produced a statistically significant reduction in HbA1c at 6 and 18 weeks and after a further 52 weeks of open-label medication most marked in poorly controlled patients with baseline HbA1c greater than 7.5 where the reduction was 0.41% within 6 weeks, and a further 0.46% after 52 weeks of open-label use. There was significant reduction in waist circumference, weight, and body mass index in men without depression, and improvements were related to achieving adequate serum levels of testosterone. There were no significant safety issues. CONCLUSIONS: Testosterone replacement therapy significantly improved HbA1c, total cholesterol, and waist circumference in men with type 2 diabetes. Improvements were less marked in men with depression at baseline, and therapeutic responses were related to achieving adequate serum testosterone levels. Current advice on 3- to 6-month trials of therapy may be insufficient to achieve maximal response. Patients reported significant improvements in general health.

Integrity signals

Registry

Crossref · 10.1111/jsm.12404

Cites

61 of 61 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • A compelling number of clinical studies demonstrated that TRT led to improvement in glycemic control and insulin sensitivity, whereas some failed to confirm these observations.

    “A compelling number of clinical studies demonstrated that TRT led to improvement in glycemic control and insulin sensitivity (4, 5, 37, 42), whereas some failed to confirm these observations (43).”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Hackett, G., Cole, N., Bhartia, M., Kennedy, D., Raju, J., Wilkinson, P., & the BLAST Study Group
Affiliations
  • Good Hope Hospital (GB)
  • Wilkinson Associates Radnet , Herts , UK
Corresponding author
Hackett, Geoffrey
Venue
The Journal of Sexual Medicine
Published
2014-03-01
Volume
11
Issue
3
Pages
840-856
ISSN
  • 1743-6095 (ISSN-L)
  • 1743-6109
OpenAlex
W1614492335
Cited by
168
References
61
Citations by year
2026: 3 · 2025: 5 · 2024: 10 · 2023: 13 · 2022: 10 · 2021: 13 · 2020: 18 · 2019: 12 · 2018: 21 · 2017: 12 · 2016: 13 · 2015: 21 · 2014: 16
FWCI
13.10
Type
journal article
Language
en
Open access
closed
Locations
  • The Journal of Sexual Medicine (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
Keywords
testosterone replacement therapy, testosterone undecanoate, hypogonadism, type 2 diabetes, depression, insulin resistance, HbA1c, waist circumference, body mass index, serum testosterone levels, sexual function, erectile dysfunction
MeSH terms
Adult, Aged, Androgens, Body Composition, Delayed-Action Preparations, Depressive Disorder, Diabetes Mellitus, Type 2, Double-Blind Method, Glycated Hemoglobin, Humans, Hypogonadism, Erectile Dysfunction, Insulin Resistance, Male, Middle Aged, Obesity, Testosterone, Body Mass Index, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review